Geneos Wealth Management Inc. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Geneos Wealth Management Inc. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$4,000
+33.3%
1000.0%0.00%
Q3 2020$3,000
-40.0%
1000.0%0.00%
Q2 2020$5,000
+66.7%
1000.0%0.00%
Q1 2020$3,000
-25.0%
1000.0%0.00%
Q4 2019$4,000
-63.6%
100
-70.3%
0.00%
-100.0%
Q3 2019$11,000
-31.2%
3370.0%0.00%0.0%
Q2 2019$16,000
-27.3%
3370.0%0.00%0.0%
Q1 2019$22,000
+46.7%
3370.0%0.00%0.0%
Q4 2018$15,000
-40.0%
3370.0%0.00%
-50.0%
Q3 2018$25,000
-10.7%
3370.0%0.00%0.0%
Q2 2018$28,000
-3.4%
337
-5.6%
0.00%
-33.3%
Q1 2018$29,000
+45.0%
3570.0%0.00%
+50.0%
Q4 2017$20,000
+122.2%
357
+160.6%
0.00%
+100.0%
Q3 2017$9,000
-59.1%
137
-68.6%
0.00%
-50.0%
Q2 2017$22,000
-12.0%
4370.0%0.00%
-33.3%
Q1 2017$25,000
+38.9%
4370.0%0.00%
+50.0%
Q4 2016$18,000
-21.7%
4370.0%0.00%
-33.3%
Q3 2016$23,000
+27.8%
4370.0%0.00%0.0%
Q2 2016$18,000
+125.0%
437
+118.5%
0.00%
+200.0%
Q1 2016$8,0002000.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
NORTHCAPE WEALTH MANAGEMENT, LLC 10,510$241,4150.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders